Showing results (461-470 of 1,072) with videos related to
Sort By:
Pageof 108
The American Journal of Cardiology|February 17, 2017
Comparison of Platelet Reactivity in Black Versus White Patients With Acute Coronary Syndromes After Treatment With TicagrelorMichael A Gaglia, Michael J Lipinski, Thibault Lhermusier, et al.Journal of the American College of Cardiology|May 26, 2012
Influence of genetic polymorphisms on the effect of high- and standard-dose clopidogrel after percutaneous coronary intervention: the GIFT (Genotype Information and Functional Testing) studyMatthew J Price, Sarah S Murray, Dominick J Angiolillo, et al.Journal of Clinical Medicine|November 11, 2022
Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for PracticeFelice Gragnano, Antonio Capolongo, Fabrizia Terracciano, et al.Cardiovascular Radiation Medicine|August 24, 2004
Intracoronary brachytherapy following drug-eluting stent failure. It's still not time to hang up the spikes!Dominick J Angiolillo, Manel Sabaté, Pilar Jiménez-Quevedo, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
Iatrogenic dissection of the ascending aorta following heart catheterisation: incidence, management and outcomeSilvia Gómez-Moreno, Manel Sabaté, Pilar Jiménez-Quevedo, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 17, 2026
Platelet FcɣRIIa Expression Refines Clinical Risk Assessment After Myocardial InfarctionDavid J Schneider, Sean R McMahon, Dominick J Angiolillo, et al.Revista Espanola De Cardiologia (English Ed.)|September 25, 2021
Rationale and design of the BA-SCAD (Beta-blockers and Antiplatelet agents in patients with Spontaneous Coronary Artery Dissection) randomized clinical trialFernando Alfonso, José M de la Torre Hernández, Borja Ibáñez, et al.Journal of Thrombosis and Thrombolysis|August 29, 2022
Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover studyFrancesco Franchi, David J Schneider, Jayne Prats, et al.Journal of the American College of Cardiology|June 16, 2012
Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease: the recovery trialMatthew J Price, James S Walder, Brian A Baker, et al.Circulation. Cardiovascular Interventions|September 26, 2013
Effect on platelet reactivity from a prasugrel loading dose after a clopidogrel loading dose compared with a prasugrel loading dose alone: Transferring From Clopidogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome Patients (TRIPLET): a randomized controlled trialJean G Diodati, Jorge F Saucedo, John K French, et al.Pageof 108